{"nct_id":"NCT03901963","title":"A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-04-26","start_date_type":"ACTUAL","primary_completion_date":"2024-04-04","primary_completion_date_type":"ACTUAL","completion_date":"2026-05-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}